A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.
Ellem KA, O'Rourke MG, Johnson GR, Parry G, Misko IS, Schmidt CW, Parsons PG, Burrows SR, Cross S, Fell A, Li CL, Bell JR, Dubois PJ, Moss DJ, Good MF, Kelso A, Cohen LK, Dranoff G, Mulligan RC.
Ellem KA, et al. Among authors: dubois pj.
Cancer Immunol Immunother. 1997 Mar;44(1):10-20. doi: 10.1007/s002620050349.
Cancer Immunol Immunother. 1997.
PMID: 9111579
Free PMC article.